Vitamin D supplementation in the prevention and management of major chronic diseases not related to mineral homeostasis in adults: research for evidence and a scientific statement from the European society for clinical and economic aspects of osteoporosis and osteoarthritis (ESCEO)

Endocrine

Volumn 56, Issue 2, 2017, Pages 245-261

  Cianferotti, Luisella ^a   Bertoldo, Francesco ^b   Bischoff Ferrari, Heike A ^c   Bruyere, Olivier ^d   Cooper, Cyrus ^e   Cutolo, Maurizio ^f   Kanis, John A ^g,h   Kaufman, Jean Marc ⁱ   Reginster, Jean Yves ^j   Rizzoli, Rene ^k   Brandi, Maria Luisa ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d UNIVERSITY OF LIÈGE   (Belgium)

^e UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^f UNIVERSITY OF GENOA   (Italy)

^g UNIVERSITY OF SHEFFIELD   (United Kingdom)

^h AUSTRALIAN CATHOLIC UNIVERSITY   (Australia)

ⁱ GHENT UNIVERSITY HOSPITAL   (Belgium)

^j UNIVERSITY OF LIÈGE   (Belgium)

^k GENEVA UNIVERSITY HOSPITALS   (Switzerland)

more..

Author keywords

Autoimmune diseases; Cancer; Cardiovascular diseases; Cholecalciferol; Diabetes; Mortality

Indexed keywords

25 HYDROXYVITAMIN D; ALFACALCIDOL; BETA INTERFERON; CALCIFEDIOL; CALCITRIOL; CALCITRIOL DERIVATIVE; CALCIUM; CARBONIC ACID; COLECALCIFEROL; ERGOCALCIFEROL; FIBROBLAST GROWTH FACTOR 23; PARATHYROID HORMONE; PLACEBO; VITAMIN D; VITAMIN D BINDING PROTEIN; VITAMIN D RECEPTOR;

ARTICLE; BIOLOGICAL ACTIVITY; BONE METASTASIS; BREAST CANCER; CANCER MORTALITY; CARDIOVASCULAR MORTALITY; COLON CANCER; COLORECTAL ADENOMA; COLORECTAL CANCER; DIABETES MELLITUS; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; HEART INFARCTION; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; METABOLIC SYNDROME X; MORTALITY; MULTIPLE SCLEROSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROSTATE CANCER; RHEUMATOID ARTHRITIS; SUDDEN CARDIAC DEATH; SYSTEMIC LUPUS ERYTHEMATOSUS; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; DIABETES MELLITUS, TYPE 1; DIETARY SUPPLEMENT; LUPUS ERYTHEMATOSUS, SYSTEMIC; PRACTICE GUIDELINE;

DIABETES MELLITUS, TYPE 1; DIETARY SUPPLEMENTS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MULTIPLE SCLEROSIS; VITAMIN D;

EID: 85017163063     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-017-1290-9     Document Type: Article

References (153)

1. G.-H. Fuleihan, R. Bouillon, B. Clarke, M. Chakhtoura, C. Cooper, M. McClung, R.J. Singh, Serum 25-hydroxyvitamin D Levels: variability, knowledge gaps, and the concept of a desirable range. J. Bone. Miner. Res. 30, 1119–1133 (2015)
2. H.A. Bischoff-Ferrari, A. Shao, B. Dawson-Hughes., J. Hathcock, E. Giovannucci, W.C. Willett, Benefit-risk assessment of vitamin D supplementation. Osteoporos. Int. 21, 1121–1132 (2010)
3. M.F. Holick, N.C. Binkley, H.A. Bischoff-Ferrari, C.M. Gordon, D.A. Hanley, R.P. Heaney, M.H. Murad, C.M. Weaver, Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited. J. Clin. Endocrinol. Metab. 97, 1153–1158 (2012)
4. C.J. Rosen, S.A. Abrams, J.F. Aloia, P.M. Brannon, S.K. Clinton, R.A. Durazo-Arvizu, J.C. Gallagher, R.L. Gallo, G. Jones, C.S. Kovacs, J.E. Manson, S.T. Mayne, A.C. Ross, S.A. Shapses, C.L. Taylor, IOM committee members respond to Endocrine Society vitamin D guideline. J. Clin. Endocrinol. Metab. 97, 1146–1152 (2012)
5. R. Rizzoli, S. Boonen, M.L. Brandi, O. Bruyère, C. Cooper, J.A. Kanis, J.M. Kaufman, J.D. Ringe, G. Weryha, J.Y. Reginster, Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Curr. Med. Res. Opin. 29, 305–313 (2013)
6. H.A. Bischoff-Ferrari, W.C. Willett, E.J. Orav, E.J. Orav, P. Lips, P.J. Meunier, R.A. Lyons, L. Flicker, J. Wark, R.D. Jackson, J.A. Cauley, H.E. Meyer, M. Pfeifer, K.M. Sanders, H.B. Stähelin, R. Theiler, B. Dawson-Hughes, A pooled analysis of vitamin D dose requirements for fracture prevention. N. Engl. J. Med. 367, 40–49 (2012)
7. H.A. Bischoff-Ferrari, B. Dawson-Hughes, E.J. Orav, H.B. Staehelin, O.W. Meyer, R. Theiler, W. Dick, W.C. Willett, A. Egli, Monthly high-dose Vitamin D Treatment for the prevention of functional decline: a randomized clinical trial. JAMA Intern. Med 176, 175–183 (2016)
8. N.M. van Schoor, P. Lips, Worldwide vitamin D status. Best. Pract. Res. Clin. Endocrinol. Metab. 25, 671–680 (2011)
9. K.D. Cashman, K.G. Dowling, Z. Škrabáková, M. Gonzalez-Gross, J. Valtueña, S. De Henauw, L. Moreno, C.T. Damsgaard, K.F. Michaelsen, C. Mølgaard, R. Jorde, G. Grimnes, G. Moschonis, C. Mavrogianni, Y. Manios, M. Thamm, G.B. Mensink, M. Rabenberg, M.A. Busch, L. Cox, S. Meadows, G. Goldberg, A. Prentice, J.M. Dekker, G. Nijpels, S. Pilz, K.M. Swart, N.M. van Schoor, P. Lips, G. Eiriksdottir, V. Gudnason, M.F. Cotch, S. Koskinen, C. Lamberg-Allardt, R.A. Durazo-Arvizu, C.T. Sempos, M. Kiely, Vitamin D deficiency in Europe: pandemic? Am. J. Clin. Nutr. 103, 1033–1044 (2016)
10. J.C. Gallagher, A. Sai, T. Templin 2nd, L. Smith, Dose response to vitamin D supplementation in postmenopausal women: a randomized trial. Ann. Intern. Med. 156, 425–437 (2012)
11. IOM. Dietary Reference Ranges for Calcium and Vitamin D, https://www.nationalacademies.org/hmd/~/media/Files/Report%20Files/2010/Dietary-Reference-Intakes-for-Calcium-and-Vitamin-D/Vitamin%20D%20and%20Calcium%202010%20Report%20Brief.pdf. Accessed 12 Dec 2016
12. S.J. Wimalawansa, Non-musculoskeletal benefits of Vitamin D. J. Steroid Biochem. Mol. Biol. pii: S0960-0760(16)30252-7. doi: 10.1016/j.jsbmb.2016.09.016. [Epub ahead of print] (2016)
13. S. Christakos, P. Dhawan, A. Verstuyf, L. Verlinden, G. Carmeliet, Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects. Physiol. Rev. 96, 365–408 (2016)
14. E. Theodoratou, I. Tzoulaki, L. Zgaga, J.P. Ioannidis, Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ 348, g2035 (2014)
15. H.A. Bischoff-Ferrari, E.J. Orav, W.C. Willett, B. Dawson-Hughes, The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes. Lancet Diabetes Endocrinol 2, 363–364 (2014)
16. C.J. Rosen, J.S. Adams, D.D. Bikle, D.M. Black, M.B. Demay, J.E. Manson, M.H. Murad, C.S. Kovacs, The nonskeletal effects of vitamin D: an endocrine society scientific statement. Endocr. Rev. 33, 456–492 (2012)
17. L. Cianferotti, S. Parri, G. Gronchi, C. Rizzuti, C. Fossi, D.M. Black, M.L. Brandi, Changing patterns of prescription in vitamin D supplementation in adults: analysis of a regional dataset. Osteoporos. Int. 26, 2695–2702 (2015)
18. S.T. Sollid, M.Y. Hutchinson, V. Berg, O.M. Fuskevåg, Y. Figenschau, P.M. Thorsby, R. Jorde, Effects of vitamin D binding protein phenotypes and vitamin D supplementation on serum total 25(OH)D and directly measured free 25(OH)D. Eur. J. Endocrinol. 174, 445–452 (2016)
19. L. Cianferotti, C. Marcocci, Subclinical vitamin D deficiency. Best. Pract. Res. Clin. Endocrinol. Metab. 26, 523–537 (2012)
20. A. Hossein-nezhad, A. Spira, M.F. Holick, Influence of vitamin D status and vitamin D3 supplementation on genome wide expression of white blood cells: a randomized double-blind clinical trial. PLoS One 8(3), e58725 (2013)
21. D.D. Bikle, Extraskeletal actions of vitamin D. Ann. N. Y. Acad. Sci. 1376, 29–52 (2016)
22. R. Bouillon, H. Bischoff-Ferrari, W. Willett, Vitamin D and health: perspectives from mice and man. J. Bone Miner. Res. 23, 974–979 (2008)
23. T. Suda, R. Masuyama, R. Bouillon, G. Carmeliet, Physiological functions of vitamin D: what we have learned from global and conditional VDRknockout mouse studies. Curr. Opin. Pharmacol. 22, 87–99 (2015)
24. L. Cianferotti, M. Cox, K. Skorija, M.B. Demay, Vitamin D receptor is essential for normal keratinocyte stem cell function. Proc. Natl Acad. Sci. USA 104, 9428–9433 (2007)
25. S. Chen, C.S. Law, C.L. Grigsby, K. Olsen, T.T. Hong, Y. Zhang, Y. Yeghiazarians, D.G. Gardner, Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy. Circulation 124, 1838–1847 (2011)
26. C. Mathieu, E. Van Etten, C. Gysemans, B. Decallonne, S. Kato, J. Laureys, J. Depovere, D. Valckx, A. Verstuyf, R. Bouillon, In vitro and in vivo analysis of the immune system of vitamin D receptor knockout mice. J. Bone Miner. Res. 16, 2057–2065 (2001)
27. L. Ceglia, S.S. Harris, Vitamin D and its role in skeletal muscle. Calcif. Tissue Int. 92, 151–162 (2013)
28. L. Song, G. Papaioannou, H. Zhao, H.F. Luderer, C. Miller, C. Dall’Osso, R.M. Nazarian, A.J. Wagers, M.B. Demay, The vitamin D receptor regulates tissue resident macrophage response to injury. Endocrinology 157, 4066–4075 (2016)
29. D.D. Bikle, Y. Oda, C.L. Tu, Y. Jiang, Novel mechanisms for the vitamin D receptor (VDR) in the skin and in skin cancer. J. Steroid Biochem. Mol. Biol. 148, 47–51 (2015)
30. Elliott, P. Sodium, potassium, body mass, alcohol and blood pressure: the intersalt study. the intersalt co-operative research group. J. Hypertens. 6, S584–S586 (2012)
31. F. Boulay, F. Berthier, O. Sisteron, Y. Gendreike, P. Gibelin, Seasonal variation in chronic heart failure hospitalizations and mortality in France. Circulation 100, 280–286 (1999)
32. P.E. Norman, J.T. Powell, Vitamin D and cardiovascular disease. Circ. Res. 114, 379–393 (2014)
33. S. Pilz, N. Verheyen, M.R. Grübler, A. Tomaschitz, W. März, Vitamin D and cardiovascular disease prevention. Nat. Rev. Cardiol. 13, 404–417 (2016)
34. A. Vaidya, J.S. Williams, The relationship between vitamin D and the renin-angiotensin system in the pathophysiology of hypertension, kidney disease, and diabetes. Metabolism 61, 450–458 (2012)
35. J.P. Forman, E. Giovannucci, M.D. Holmes, H.A. Bischoff-Ferrari, S.S. Tworoger, W.C. Willett, G.C. Curhan, Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 49, 1063–1069 (2007)
36. J.P. Forman, H.A. Bischoff-Ferrari, W.C. Willett, M.J. Stampfer, G.C. Curhan, Vitamin D intake and risk of incident hypertension: results from three large prospective cohort studies. Hypertension 46, 676–682 (2005)
37. E. Giovannucci, Y. Liu, B.W. Hollis, E.B. Rimm, 25-Hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch. Intern. Med. 168, 1174–1180 (2008)
38. H. Dobnig, S. Pilz, H. Scharnagl, W. Renner, U. Seelhorst, B. Wellnitz, J. Kinkeldei, B.O. Boehm, G. Weihrauch, W. Maerz, Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch. Intern. Med. 168, 1340–1349 (2008)
39. S. Pilz, H. Dobnig, G. Nijpels, R.J. Heine, C.D. Stehouwer, M.B. Snijder, R.M. van Dam, J.M. Dekker, Vitamin D and mortality in older men and women. Clin. Endocrinol. 71, 666–672 (2009)
40. H. Johansson, A. Odén, J. Kanis, E. McCloskey, M. Lorentzon, Ö. Ljunggren, M.K. Karlsson, P.M. Thorsby, Å. Tivesten, E. Barrett-Connor, C. Ohlsson, D. Mellström, Low serum vitamin D is associated with increased mortality in elderly men: MrOS Sweden. Osteoporos. Int. 23, 991–999 (2012)
41. J. El Hilali, E.J. de Koning, A.J. van Ballegooijen, P. Lips, E. Sohl, H.W. van Marwijk, M. Visser, N.M. van Schoor, Vitamin D, PTH and the risk of overall and disease-specific mortality: results of the longitudinal aging study Amsterdam. J. Steroid Biochem. Mol. Biol. 164, 386–394 (2015)
42. M.L. Melamed, P. Muntner, E.D. Michos, J. Uribarri, C. Weber, J. Sharma, P. Raggi, Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004. Arterioscler. Thromb. Vasc. Biol. 28, 1179–1185 (2008)
43. K.S. Vimaleswaran, A. Cavadino, D.J. Berry; LifeLines Cohort Study investigators; International Consortium for Blood Pressure (ICBP); Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium; Global Blood Pressure Genetics (Global BPGen) consortium., Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelianrandomisation study. Lancet Diabetes Endocrinol. 2, 719–729 (2014)
44. O. Trummer, S. Pilz, M.M. Hoffmann, B.R. Winkelmann, B.O. Boehm, W. März, T.R. Pieber, B. Obermayer-Pietsch, W. Renner, Vitamin D and mortality: a Mendelian randomization study. Clin. Chem. 59, 793–797 (2013)
45. R. Krause, M. Bühring, W. Hopfenmüller, M.F. Holick, A.M. Sharma, Ultraviolet B and blood pressure. Lancet 352, 709–710 (1998)
46. M. Pfeifer, B. Begerow, H.W. Minne, D. Nachtigall, C. Hansen, Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J. Clin. Endocrinol. Metab. 86, 1633–1637 (2001)
47. H.A. Bischoff-Ferrari, B. Dawson-Hughes, E. Stöcklin, E. Sidelnikov, W.C. Willett, J.O. Edel, H.B. Stähelin, S. Wolfram, A. Jetter, J. Schwager, J. Henschkowski, A. von Eckardstein, A. Egli, Oral supplementation with 25(OH)D3 versus vitamin D3: effects on 25(OH)D levels, lower extremity function, blood pressure, and markers of innate immunity. J. Bone Miner. Res. 27, 160–169 (2012)
48. S. Pilz, M. Gaksch, K. Kienreich, M. Grübler, N. Verheyen, A. Fahrleitner-Pammer, G. Treiber, C. Drechsler, B. Ó Hartaigh, B. Obermayer-Pietsch, V. Schwetz, F. Aberer, J. Mader, H. Scharnagl, A. Meinitzer, E. Lerchbaum, J.M. Dekker, A. Zittermann, W. März, A. Tomaschitz, Effects of vitamin D on blood pressure and cardiovascular risk factors: a randomized controlled trial. Hypertension 65, 1195–1201 (2015)
49. M.R. Grübler, M. Gaksch, K. Kienreich, N. Verheyen, J. Schmid, B.W. Ó Hartaigh, G. Richtig, H. Scharnagl, A. Meinitzer, B. Pieske, A. Fahrleitner-Pammer, W. März, A. Tomaschitz, S. Pilz, Effects of vitamin D supplementation on plasma aldosterone and renin—a randomized placebo-controlled trial. J. Clin. Hypertens. 18, 608–613 (2016)
50. M.D. Witham, M.A. Nadir, A.D. Struthers, Effect of vitamin D on blood pressure: a systematic review and meta-analysis. J. Hypertens. 27, 1948–1954 (2009)
51. S.H. Wu, S.C. Ho, L. Zhong, Effects of vitamin D supplementation on blood pressure. South. Med. J. 103, 729–737 (2010)
52. A.G. Pittas, M. Chung, T. Trikalinos, J. Mitri, M. Brendel, K. Patel, A.H. Lichtenstein, J. Lau, E.M. Balk, Systematic review: vitamin D and cardiometabolic outcomes. Ann. Intern. Med. 152, 307–314 (2010)
53. M.B. Elamin, N.O. Abu Elnour, K.B. Elamin, M.M. Fatourechi, A.A. Alkatib, J.P. Almandoz, H. Liu, M.A. Lane, R.J. Mullan, A. Hazem, P.J. Erwin, D.D. Hensrud, M.H. Murad, V.M. Montori, Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 96, 1931–1942 (2011)
54. L.A. Beveridge, A.D. Struthers, F. Khan, R. Jorde, R. Scragg, H.M. Macdonald, J.A. Alvarez, R.S. Boxer, A. Dalbeni, A.D. Gepner, N.M. Isbel, T. Larsen, J. Nagpal., W.G. Petchey, H. Stricker, F. Strobel., V. Tangpricha, L. Toxqui, M.P. Vaquero, L. Wamberg, A. Zittermann, M.D. Witham; D-PRESSURE Collaboration. Effect of Vitamin D Supplementation on Blood Pressure, A systematic review and meta-analysis incorporating individual patient data. JAMA Intern. Med 175, 745–754 (2015)
55. G. Bjelakovic, L.L. Gluud, D. Nikolova, K. Whitfield, J. Wetterslev, R.G. Simonetti, M. Bjelakovic, C. Gluud: Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst. Rev. (1):CD007470. doi:10.1002/14651858.CD007470.pub3 (2014)
56. M.J. Bolland, A. Grey, G.D. Gamble, I.R. Reid, The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. Lancet Diabetes Endocrinol 2, 307–320 (2014)
57. J.A. Ford, G.S. MacLennan, A. Avenell, M. Bolland, A. Grey, M. Witham; Record Trial Group., Cardiovascular disease and vitamin D supplementation: trial analysis, systematic review, and meta-analysis. Am. J. Clin. Nutr. 100, 746–755 (2014)
58. M. Visser, D.J. Deeg, M.T. Puts, J.C. Seidell, P. Lips, Low serum concentrations of 25-hydroxyvitamin D in older persons and the risk of nursing home admission. Am. J. Clin. Nutr. 84, 616–622 (2006)
59. A.A. Ginde, R. Scragg, R.S. Schwartz, C.A. Camargo Jr., Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. Adults. J. Am. Geriatr. Soc. 57, 1595–1603 (2009)
60. M.L. Melamed, E.D. Michos, W. Post, B. Astor, 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Arch. Intern. Med. 168, 1629–1637 (2008)
61. A. Zittermann, S.S. Schleithoff, S. Frisch, C. Götting, J. Kuhn, H. Koertke, K. Kleesiek, G. Tenderich, R. Koerfer, Circulating calcitriol concentrations and total mortality. Clin. Chem. 55, 1163–1170 (2009)
62. R. Chowdhury, S. Kunutsor, A. Vitezova, C. Oliver-Williams, S. Chowdhury, J.C. Kiefte-de-Jong, H. Khan, C.P. Baena, D. Prabhakaran, M.B. Hoshen, B.S. Feldman, A. Pan, L. Johnson, F. Crowe, F.B. Hu, O.H. Franco, Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ. 348, g1903 (2014)
63. T. Skaaby, L.L. Husemoen, C. Pisinger, T. Jorgensen, B.H. Thuesen, M. Fenger, A. Linnerberg, Vitamin D status and incident cardiovascular disease and all-cause mortality: a general population study. Endocrine 43, 618–625 (2013)
64. K. Michaëlsson, J.A. Baron, G. Snellman, R. Gedeborg, L. Byberg, J. Sundström, L. Berglund, J. Arnlöv, P. Hellman, R. Blomhoff, A. Wolk, H. Garmo, L. Holmberg, H. Melhus, Plasma vitamin D and mortality in older men: a community-based prospective cohort study. Am. J. Clin. Nutr. 92, 841–848 (2010)
65. S. Pilz, M. Grübler, M. Gaksch, V. Schwetz, C. Trummer, B.Ó. Hartaigh, N. Verheyen, A. Tomaschitz, W. März, Vitamin D and mortality. Anticancer Res. 36, 1379–1387 (2016)
66. A. Aleksova, A.P. Beltrami, R. Belfiore, G. Barbati, M. Di Nucci, S. Scapol, V. De Paris, C. Carriere, G. Sinagra, U-shaped relationship between vitamin D levels and long-term outcome in large cohort of survivors of acute myocardial infarction. Int. J. Cardiol. 223, 962–966 (2016)
67. W.B. Grant, S.N. Karras, H.A. Bischoff-Ferrari, C. Annweiler, B.J. Boucher, A. Juzeniene, C.F. Garland, M.F. Holick, Do studies reporting ‘U’-shaped serum 25-hydroxyvitamin D-health outcome relationships reflect adverse effects? Dermato-Endocrinology 8, e1187349 (2016)
68. J.E. Manson, S.S. Bassuk, I.M. Lee, N.R. Cook, M.A. Albert, D. Gordon, E. Zaharris, J.G. Macfadyen, E. Danielson, J. Lin, S.M. Zhang, J.E. Buring, The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp. Clin. Trials 33, 159–171 (2012)
69. Zurich EC-Uo. http://do-health.eu/wordpress/. Accessed 12 Dec 2016
70. J. Mitri, A.G. Pittas, Vitamin D and diabetes. Endocrinol. Metab. Clin. N. Am. 43, 205–232 (2014)
71. A.W. Norman, J.B. Frankel, A.M. Heldt, G.M. Grodsky, Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 209, 823–825 (1980)
72. M.C. d’Emden, M. Dunlop, R.G. Larkins, J.D. Wark, The in vitro effect of 1 alpha,25-dihydroxyvitamin D3 on insulin production by neonatal rat islets. Biochem. Biophys. Res. Commun. 164, 413–418 (1989)
73. I. Zostautiene, R. Jorde, H. Schirmer, E.B. Mathiesen, I. Njølstad, M.L. Løchen, T. Wilsgaard, R.M. Joakimsen, E. Kamycheva, Genetic variations in the Vitamin D receptor predict type 2 diabetes and myocardial infarction in a community-based population: the Tromsø study. PLoS. One 10(12), e0145359 (2015)
74. R. Scragg, M. Sowers, C. Bell; Third National Health and Nutrition Examination Survey., Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the third National Health and Nutrition Examination Survey. Diabetes. Care 27, 2813–2818 (2004)
75. A.G. Pittas, B. Dawson-Hughes, T. Li, R.M. Van Dam, W.C. Willett, J.E. Manson, F.B. Hu, Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 29, 650–656 (2006)
76. M. Herrmann, D.R. Sullivan, A.S. Veillard, T. McCorquodale, I.R. Straub, R. Scott, M. Laakso, D. Topliss, A.J. Jenkins, S. Blankenberg, A. Burton, A.C. Keech; Field Study Investigators., Serum 25-hydroxyvitamin D: a predictor of macrovascular and microvascular complications in patients with type 2 diabetes. Diabetes Care 38, 521–528 (2015)
77. Y. Song, L. Wang, A.G. Pittas, L.C. Del Gobbo, C. Zhang, J.E. Manson, F.B. Hu, Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care 36, 1422–1428 (2013)
78. Z. Ye, S.J. Sharp, S. Burgess, R.A. Scott, F. Imamura; InterAct Consortium, C. Langenberg, N.J. Wareham, N.G. Forouhi, Association between circulating 25-hydroxyvitamin D and incident type 2 diabetes: a mendelian randomisation study. Lancet Diabetes Endocrinol. 3, 35–42 (2015)
79. K.S. Vimaleswaran, D.J. Berry, C. Lu, E. Tikkanen, S. Pilz, L.T. Hiraki, J.D. Cooper, Z. Dastani, R. Li, D.K. Houston, A.R. Wood, K. Michaëlsson, L. Vandenput, L. Zgaga, L.M. Yerges-Armstrong, M.I. McCarthy, J. Dupuis, M. Kaakinen, M.E. Kleber, K. Jameson, N. Arden, O. Raitakari, J. Viikari, K.K. Lohman, L. Ferrucci, H. Melhus, E. Ingelsson, L. Byberg, L. Lind, M. Lorentzon, V. Salomaa, H. Campbell, M. Dunlop, B.D. Mitchell, K.H. Herzig, A. Pouta, A.L. Hartikainen; Genetic Investigation of Anthropometric Traits-GIANT Consortium, E.A. Streeten, E. Theodoratou, A. Jula, N.J. Wareham, C. Ohlsson, T.M. Frayling, S.B. Kritchevsky, T.D. Spector, J.B. Richards, T. Lehtimäki, W.H. Ouwehand, P. Kraft, C. Cooper, W. März, C. Power, R.J. Loos, T.J. Wang, M.R. Järvelin, J.C. Whittaker, A.D. Hingorani, E. Hyppönen, Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med. 10(2), e1001383 (2013)
80. P.D. Chandler, L. Wang, X. Zhang, H.D. Sesso, M.V. Moorthy, O. Obi, J. Lewis, R.L. Prince, J.S. Danik, J.E. Manson, M.S. LeBoff, Y. Song, Effect of vitamin D supplementation alone or with calcium on adiposity measures: a systematic review and meta-analysis of randomized controlled trials. Nutr. Rev. 73, 577–593 (2015)
81. J.C. Seida, J. Mitri, I.N. Colmers, S.R. Majumdar, M.B. Davidson, A.L. Edwards, D.A. Hanley, A.G. Pittas, L. Tjosvold, J.A. Johnson, Clinical review: effect of vitamin D3 supplementation on improving glucose homeostasis and preventing diabetes: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 99, 3551–3560 (2014)
82. C. Gagnon, R.M. Daly, A. Carpentier, Z.X. Lu, C. Shore-Lorenti, K. Sikaris, S. Jean, P.R. Ebeling, Effects of combined calcium and vitamin D supplementation on insulin secretion, insulin sensitivity and β-cell function in multi-ethnic vitamin D-deficient adults at risk for type 2 diabetes: a pilot randomized, placebo-controlled trial. PLoS One 9(10), e109607 (2014)
83. D.M. Mitchell, B.Z. Leder, E. Cagliero, N. Mendoza, M.P. Henao, D.L. Hayden, J.S. Finkelstein, S.A. Burnett-Bowie, Insulin secretion and sensitivity in healthy adults with low vitamin D are not affected by high-dose ergocalciferol administration: a randomized controlled trial. Am. J. Clin. Nutr. 102, 385–392 (2015)
84. R. Jorde, S.T. Sollid, J. Svartberg, H. Schirmer, R.M. Joakimsen, I. Njølstad, O.M. Fuskevåg, Y. Figenschau, M.Y. Hutchinson, Vitamin D 20,000 IU per week for five years does not prevent progression from prediabetes to diabetes. J. Clin. Endocrinol. Metab. 101, 1647–1655 (2016)
85. A.G. Pittas, B. Dawson-Hughes, P.R. Sheehan, C.J. Rosen, J.H. Ware, W.C. Knowler, M.A. Staten; D2d Research Group., Rationale and design of the vitamin D and type 2 diabetes (D2d) study: a diabetes prevention trial. Diabetes Care 37, 3227–3234 (2014)
86. L. Adorini, G. Penna, Control of autoimmune diseases by the vitamin D endocrine system. Nat. Clin. Pract. Rheumatol. 4, 404–412 (2008)
87. M. Cutolo, Further emergent evidence for the vitamin D endocrine system involvement in autoimmune rheumatic disease risk and prognosis. Ann. Rheum. Dis. 72(4), 473–475 (2013)
88. Y. Rosen, J. Daich, I. Soliman, E. Brathwaite, Y. Shoenfeld, Vitamin D and autoimmunity. Scand. J. Rheumatol. 45, 439–447 (2016)
89. A.L. Ponsonby, R.M. Lucas, I.A. van der Mei, UVR, vitamin D and three autoimmune diseases-multiple sclerosis, type 1 diabetes, rheumatoid arthritis. Photochem. Photobiol. 81, 1267–1275 (2005)
90. S.B. Mohr, C.F. Garland, E.D. Gorham, F.C. Garland, The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1diabetes in 51 regions worldwide. Diabetologia 51, 1391–1398 (2008)
91. M. Cutolo, Rheumatoid arthritis: circadian and circannual rhythms in RA. Nat. Rev. Rheumatol. 7, 500–502 (2011)
92. X.C. Dopico, M. Evangelou, R.C. Ferreira, H. Guo, M.L. Pekalski, D.J. Smyth, N. Cooper, O.S. Burren, A.J. Fulford, B.J. Hennig, A.M. Prentice, A.G. Ziegler, E. Bonifacio, C. Wallace, J.A. Todd, Widespread seasonal gene expression reveals annual differences in human immunity and physiology. Nat. Commun. 6, 7000 (2015)
93. B.R. Becklund, K.S. Severson, S.V. Vang, H.F. DeLuca, UV radiation suppresses experimental autoimmune encephalomyelitis independent of vitamin D production. Proc. Natl Acad. Sci. USA 107, 6418–6423 (2010)
94. R. Wei, S. Christakos, Mechanisms underlying the regulation of innate and adaptive immunity by Vitamin D. Nutrients 7, 8251–8560 (2015)
95. B. Villaggio, S. Soldano, M. Cutolo, 1,25-Dihydroxyvitamin D3 downregulates aromatase expression and inflammatory cytokines in human macrophages. Clin. Exp. Rheumatol. 30, 934–938 (2012)
96. Y. Wang, S.J. Marling, J.G. Zhu, K.S. Severson, H.F. DeLuca, Development of experimental autoimmune encephalomyelitis (EAE) in mice requires vitamin D and the vitamin D receptor. Proc. Natl Acad. Sci. USA 109, 8501–8504 (2012)
97. G.B. Ferreira, C.A. Gysemans, J. Demengeot, J.P. da Cunha, A.S. Vanherwegen, L. Overbergh, T.L. Van Belle, F. Pauwels, A. Verstuyf, H. Korf, C. Mathieu, 1,25-Dihydroxyvitamin D3 promotes tolerogenic dendritic cells with functional migratory properties in NOD mice. J. Immunol. 192, 4210–4220 (2014)
98. T. Skaaby, L. Husemoen, B. Thuesen, A. Linneberg, Prospective population-based study of the association between vitamin D status and incidence of autoimmune disease. Endocrine 50, 231–238 (2015)
99. S. Duan, Z. Lv, X. Fan, L. Wang, F. Han, H. Wang, S. Bi, Vitamin D status and the risk of multiple sclerosis: a systematic review and meta-analysis. Neurosci. Lett. 570, 108–113 (2014)
100. L.E. Mokry, S. Ross, O.S. Ahmad, V. Forgetta, G.D. Smith, D. Goltzman, A. Leong, C.M. Greenwood, G. Thanassoulis, J.B. Richards, Vitamin D and risk of multiple sclerosis: a mendelian randomization study. PLoS Med. 12(8), e1001866 (2015)
101. B. Rhead, M. Bäärnhielm, M. Gianfrancesco, A. Mok, X. Shao, H. Quach, L. Shen, C. Schaefer, J. Link, A. Gyllenberg, A.K. Hedström, T. Olsson, J. Hillert, I. Kockum, M.M. Glymour, L. Alfredsson, L.F. Barcellos, Mendelian randomization shows a causal effect of low vitamin D on multiple sclerosis risk. Neurol. Genet 2(5), e97 (2016)
102. A. Ascherio, K.L. Munger, R. White, K. Köchert, K.C. Simon, C.H. Polman, M.S. Freedman, H.P. Hartung, D.H. Miller, X. Montalbán, G. Edan, F. Barkhof, D. Pleimes, E.W. Radü, R. Sandbrink, L. Kappos, C. Pohl, Vitamin D as an early predictor of multiple sclerosis activity and progression. JAMA Neurol. 71, 306–314 (2014)
103. K.C. Fitzgerald, K.L. Munger, K. Köchert, B.G. Arnason, G. Comi, S. Cook, D.S. Goodin, M. Filippi, H.P. Hartung, D.R. Jeffery, P. O’Connor, G. Suarez, R. Sandbrink, L. Kappos, C. Pohl, A. Ascherio, Association of Vitamin D levels with multiple sclerosis activity and progression in patients receiving interferon Beta-1b. JAMA Neurol 72, 1458–1465 (2015)
104. N. Stewart, S. Simpson Jr, I. van der Mei, A.L. Ponsonby, L. Blizzard, T. Dwyer, F. Pittas, D. Eyles, P. Ko, B.V. Taylor, Interferon-β and serum 25-hydroxyvitamin D interact to modulate relapse risk in MS. Neurology 79, 254–260 (2012)
105. G. Bock, B. Prietl, J.K. Mader, E. Höller, M. Wolf, S. Pilz, W.B. Graninger, B.M. Obermayer-Pietsch, T.R. Pieber, The effect of vitamin D supplementation on peripheral regulatory T cells and β cell function in healthy humans: a randomized controlled trial. Diabetes.Metab. Res. Rev. 27, 942–945 (2011)
106. G.G. Konijeti, P. Arora, M.R. Boylan, Y. Song, S. Huang, F. Harrell, C. Newton-Cheh, D. O’Neill, J. Korzenik, T.J. Wang, A.T. Chan, Vitamin D supplementation modulates T cell-mediated immunity in humans: results from a randomized control trial. J. Clin. Endocrinol. Metab. 101, 533–538 (2016)
107. F. Ashtari, N. Toghianifar, S.H. Zarkesh-Esfahani, M. Mansourian, High dose Vitamin D intake and quality of life in relapsing-remitting multiple sclerosis: arandomized, double-blind, placebo-controlled clinical trial. Neurol. Res. 38, 888–892 (2016)
108. E.S. Sotirchos, P. Bhargava, C. Eckstein, K. Van Haren, M. Baynes, A. Ntranos, A. Gocke, L. Steinman, E.M. Mowry, P.A. Calabresi, Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis. Neurology 86, 382–390 (2016)
109. B. Pozuelo-Moyano, J. Benito-León, A.J. Mitchell, J. Hernández-Gallego, A systematic review of randomized, double-blind, placebo-controlled trials examining the clinical efficacy of vitamin D in multiple sclerosis. Neuroepidemiology 40, 147–153 (2013)
110. E. Hyppönen, E. Läärä, A. Reunanen, M.R. Järvelin, S.M. Virtanen, Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 358, 1500–1503 (2001)
111. T. Takiishi, L. Ding, F. Baeke, I. Spagnuolo, G. Sebastiani, J. Laureys, A. Verstuyf, G. Carmeliet, F. Dotta, T.L. Van Belle, C.A. Gysemans, C. Mathieu, Dietary supplementation with high doses of regular vitamin D3 safely reduces diabetes incidence in NOD mice when given early and long term. Diabetes 63, 2026–2036 (2014)
112. X. Li, L. Liao, X. Yan, G. Huang, J. Lin, M. Lei, X. Wang, Z. Zhou, Protective effects of 1-alpha-hydroxyvitamin D3 on residual beta-cell function in patients with adult-onset latent autoimmune diabetes (LADA). Diabetes Metab. Res. Rev. 25, 411–416 (2009)
113. G. Treiber, B. Prietl, E. Fröhlich-Reiterer, E. Lechner, A. Ribitsch, M. Fritsch, B. Rami-Merhar, C. Steigleder-Schweiger, W. Graninger, M. Borkenstein, T.R. Pieber, Cholecalciferol supplementation improves suppressive capacity of regulatory T-cells in young patients with new-onset type 1 diabetes mellitus—a randomized clinical trial. Clin. Immunol. 161, 217–224 (2015)
114. M. Cutolo, K. Otsa, K. Laas, M. Yprus, R. Lehtme, M.E. Secchi, A. Sulli, S. Paolino, B. Seriolo, Circannual vitamin d serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe. Clin. Exp. Rheumatol. 24, 702–704 (2006)
115. M. Cutolo, C. Pizzorni, A. Sulli, Vitamin D endocrine system involvement in autoimmune rheumatic diseases. Autoimmun. Rev. 11, 84–87 (2011)
116. D.J. Birmingham, L.A. Hebert, H. Song, W.T. Noonan, B.H. Rovin, H.N. Nagaraja, C.Y. Yu, Evidence that abnormally large seasonal declines in vitamin D status may trigger SLE flare in non-African Americans. Lupus 21, 855–864 (2012)
117. M. Racovan, B. Walitt, C.E. Collins, M. Pettinger, C.G. Parks, J.M. Shikany, J. Wactawski-Wende, J.E. Manson, L. Moreland, N. Wright, R. Jackson, B.V. Howard, Calcium and vitamin D supplementation and incident rheumatoid arthritis: the Women’s Health initiative calcium plus Vitamin D trial. Rheumatol. Int. 32, 3823–3830 (2012)
118. K.H. Costenbader, D. Feskanich, M. Holmes, E.W. Karlson, E. Benito-Garcia, Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women. Ann. Rheum. Dis. 67, 530–535 (2008)
119. G.G. Song, S.C. Bae, Y.H. Lee, Association between vitamin D intake and the risk of rheumatoid arthritis: a meta-analysis. Clin. Rheumatol. 31, 1733–1739 (2012)
120. J. Lin, J. Liu, M.L. Davies, W. Chen, Serum Vitamin D level and rheumatoid arthritis disease activity: review and meta-analysis. PLoS One 11(1), e0146351 (2016)
121. A. Abou-Raya, S. Abou-Raya, M. Helmii, The effect of vitamin D supplementation on inflammatory and hemostatic markers and disease activity in patients with systemic lupus erythematosus: a randomized placebo-controlled trial. J. Rheumatol. 40, 265–272 (2013)
122. S. Piantoni, L. Andreoli, M. Scarsi, A. Zanola, F. Dall’Ara, C. Pizzorni, M. Cutolo, P. Airò, A. Tincani, Phenotype modifications of T-cells and their shift toward a Th2 response in patients with systemic lupus erythematosus supplemented with different monthly regimens of vitamin D. Lupus 24, 490–498 (2015)
123. L. Andreoli, F. Dall’Ara, S. Piantoni, A. Zanola, N. Piva, M. Cutolo, A. Tincani, A 24-month prospective study on the efficacy and safety of two different monthly regimens of vitamin D supplementation in pre-menopausal women with systemic lupus erythematosus. Lupus 24(4-5), 499–506 (2015)
124. S. Straube, S. Derry, C. Straube, R.A. Moore, Vitamin D for the treatment of chronic painful conditions in adults. Cochrane Database Syst. Rev. (5):CD007771. doi:10.1002/14651858.CD007771.pub3 (2015)
125. J.C. Fleet, M. DeSmet, R. Johnson, Y. Li, Vitamin D and cancer: a review of molecular mechanisms. Biochem. J. 441, 61–76 (2012)
126. D.D. Bikle, Y. Jiang, T. Nguyen, Y. Oda, C.L. Tu, Disruption of vitamin D and calcium signaling in keratinocytes predisposes to skin cancer. Front. Physiol 7, 296 (2016)
127. Y. Zheng, H. Zhou, L.L. Ooi, A.D. Snir, C.R. Dunstan, M.J. Seibel, Vitamin D deficiency promotes prostate cancer growth in bone. Prostate 71(9), 1012–1021 (2011)
128. D. Santini, F. Pantano, B. Vincenzi, G. Tonini, F. Bertoldo, The role of bone microenvironment, vitamin D and calcium. Recent Results Cancer Res. 192, 33–64 (2012)
129. C.F. Garland, F.C. Garland, E.D. Gorham, M. Lipkin, H. Newmark, S.B. Mohr, M.F. Holick, The role of vitamin D in cancer prevention. Am. J. Public Health 96, 252–261 (2006)
130. E. Giovannucci, The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control 16, 83–95 (2005)
131. K.D. Crew, E. Shane, S. Cremers, D.J. McMahon, D. Irani, D.L. Hershman, High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy. J. Clin. Oncol. 27, 2151–2156 (2009)
132. H. Li, M.J. Stampfer, J.B. Hollis, L.A. Mucci, J.M. Gaziano, D. Hunter, E.L. Giovannucci, J. Ma, A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer. PLoS Med. 4(3), e103 (2007)
133. T.C. Chen, A. Kittaka Novel vitamin D analogs for prostate cancer therapy. ISRN Urol. 2011:301490 (2011)
134. C.F. Garland, E.D. Gorham, S.B. Mohr, F.C. Garland, Vitamin D for cancer prevention: global perspective. Ann. Epidemiol. 19, 468–483 (2009)
135. M. Waterhouse, H.A. Risch, C. Bosetti, K.E. Anderson, G.M. Petersen, W.R. Bamlet, M. Cotterchio, S.P. Cleary, T.I. Ibiebele, C. La Vecchia, H.G. Skinner, L. Strayer, P.M. Bracci, P. Maisonneuve, H.B. Bueno-de-Mesquita, W. Zatoński, L. Lu, H. Yu, K. Janik-Koncewicz, J. Polesel, D. Serraino, R.E. Neale; Pancreatic Cancer Case–Control Consortium (PanC4)., Vitamin D and pancreatic cancer: a pooled analysis from the Pancreatic cancer case–control consortium. Ann. Oncol. 27, 208 (2016)
136. M.J. Mun, T.H. Kim, J.Y. Hwang, W.C. Jang, Vitamin D receptor gene polymorphisms and the risk for female reproductive cancers: a meta-analysis. Maturitas 81, 256–265 (2015)
137. E. Tagliabue, S. Raimondi, S. Gandini, Meta-analysis of vitamin D-binding protein and cancer risk. Cancer Epidemiol. Biomark. Prev. 24, 1758–1765 (2015)
138. J.E. Manson, S.T. Mayne, S.K. Clinton, Vitamin D and prevention of cancer-ready for prime time? N. Engl. J. Med. 364, 1385–1387 (2011)
139. J.M. Lappe, D. Travers-Gustafson, K.M. Davies, R.R. Recker, R.P. Heaney, Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am. J. Clin. Nutr. 85, 1586–1591 (2007)
140. M. Chung, J. Lee, T. Terasawa, J. Lau, T.A. Trikalinos, Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task Force. Ann. Intern. Med. 155, 827–838 (2011)
141. G. Bjelakovic, L.L. Gluud, D. Nikolova, K. Whitfield, G. Krstic, J. Wetterslev, C. Gluud, Vitamin D supplementation for prevention of cancer in adults. Cochrane Database Syst. Rev. (6):CD007469. doi:10.1002/14651858.CD007469.pub2 (2014)
142. J.A. Baron, E.L. Barry, L.A. Mott, J.R. Rees, R.S. Sandler, D.C. Snover, R.M. Bostick, A. Ivanova, B.F. Cole, D.J. Ahnen, G.J. Beck, R.S. Bresalier, C.A. Burke, T.R. Church, M. Cruz-Correa, J.C. Figueiredo, M. Goodman, A.S. Kim, D.J. Robertson, R. Rothstein, A. Shaukat, M.E. Seabrook, R.W. Summers, A trial of calcium and vitamin D for the prevention of colorectal adenomas. N. Engl. J. Med. 373, 1519–1530 (2015)
143. N. Keum, E. Giovannucci, Vitamin D supplements and cancer incidence and mortality: a meta-analysis. Br. J. Cancer 111, 976–980 (2014)
144. M. Jeffreys, M.T. Redaniel, R.M. Martin, The effect of pre-diagnostic vitamin D supplementation on cancer survival in women: a cohort study within the UK clinical practice research datalink. BMC Cancer 15, 670 (2015)
145. M. Ben-Eltriki, S. Deb, E.S. Guns, Calcitriol in combination therapy for prostate cancer: pharmacokinetic and pharmacodynamic interactions. J. Cancer 7, 391–407 (2016)
146. A. Berruti, R. Cook, F. Saad, C. Buttigliero, A. Lipton, M. Tampellini, K.A. Lee, R.E. Coleman, M.R. Smith, Prognostic role of serum parathyroid hormone levels in advanced prostate cancer patients undergoing zoledronic acid administration. Oncologist 17, 645–652 (2012)
147. F. Saad, D.M. Gleason, R. Murray, S. Tchekmedyian, P. Venner, L. Lacombe, J.L. Chin, J.J. Vinholes, J.A. Goas, B. Chen; Zoledronic Acid Prostate Cancer Study Group., A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma. J. Natl Cancer. Inst. 94, 1458–1468 (2002)
148. R. Rizzoli, J.J. Body, M.L. Brandi, J. Cannata-Andia, D. Chappard, A. El Maghraoui, C.C. Glüer, D. Kendler, N. Napoli, A. Papaioannou, D.D. Pierroz, M. Rahme, C.H. Van Poznak, T.J. de Villiers, G. El Hajj Fuleihan; International Osteoporosis Foundation Committee of Scientific Advisors Working Group on Cancer-Induced Bone Disease., Cancer-associated bone disease. Osteoporos. Int. 24, 2929–2953 (2013)
149. D.J. Berry, K.S. Vimaleswaran, J.C. Whittaker, A.D. Hingorani, E. Hyppönen, Evaluation of genetic markers as instruments for Mendelian randomization studies on vitamin D. PLoS One 7(5), e37465 (2012)
150. K.M. Sanders, A.L. Stuart, E.J. Williamson, J.A. Simpson, M.A. Kotowicz, D. Young, G.C. Nicholson, Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 303, 1815–1822 (2010)
151. A.T. Slominski, T.K. Kim, J.V. Hobrath, A.S. Oak, E.K. Tang, E.W. Tieu, W. Li, R.C. Tuckey, A.M. Jetten, Endogenously produced nonclassical vitamin D hydroxy-metabolites act as “biased” agonists on VDR and inverse agonists on RORα and RORγ. J Steroid Biochem. Mol. Biol. pii: S0960-0760(16)30260-6. doi:10.1016/j.jsbmb.2016.09.024. [Epub ahead of print] (2016)
152. J.C. Gallagher, Vitamin D and falls—the dosage conundrum. Nat. Rev. Endocrinol 12, 680–684 (2016)
153. M. Herrmann, C.L. Farrell, I. Pusceddu, N. Fabregat-Cabello, E. Cavalier, Assessment of vitamin D status—a changing landscape. Clin. Chem. Lab. Med. 55, 3–26 (2017)